Page last updated: 2024-10-25

eucalyptol and Cardiomyopathies

eucalyptol has been researched along with Cardiomyopathies in 2 studies

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Alves-Silva, JM1
Zuzarte, M1
Marques, C1
Viana, S1
Preguiça, I1
Baptista, R1
Ferreira, C1
Cavaleiro, C1
Domingues, N1
Sardão, VA1
Oliveira, PJ1
Reis, F1
Salgueiro, L1
Girão, H1
He, Z1

Other Studies

2 other studies available for eucalyptol and Cardiomyopathies

ArticleYear
1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis.
    Pharmacological research, 2022, Volume: 180

    Topics: Animals; Cardiomyopathies; Connexin 43; Disease Models, Animal; Eucalyptol; Heart Ventricles; Homeos

2022
Comment on "1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis".
    Pharmacological research, 2023, Volume: 191

    Topics: Cardiomyopathies; Connexin 43; Eucalyptol; Heart Ventricles; Humans; Hypertension, Pulmonary; Pulmon

2023